Table 3. Overweight-associated mortality risk.
Target parameter | Exposure | Reference | Risk (95% CI) | Source | |
Women | Men | ||||
All cause mortality | BMI >25 to <30 | BMI ≥18.5 to 25 | RR = 0.97 (0.93 to 0.99) | RR = 0.97 (0.92 to 1.01) | Meta-analysis (6) |
BMI 25.0 to <26.5 | BMI 23.5 to 25 | RR = 1.01 (0.92 to 1.11) | RR = 0.91 (0.84 to 0.99) | Cohort study (5) | |
BMI 26.5 to <28.0 | BMI 23.5 to 25 | RR = 1.07 (0.97 to 1.18) | RR = 0.96 (0.88 to 1.04) | Cohort study (5) | |
BMI 28.0 to <30.0 | BMI 23.5 to 25 | RR = 1.11 (1.00 to 1.22) | RR = 1.08 (1.00 to 1.17) | Cohort study (5) | |
Overall cancer mortality | BMI >25 to <30 | BMI ≥18.5 to 25 | RR = 0.99 (0.92 to 1.05) | RR = 0.93 (0.89 to 0.97) | Meta-analysis (6) |
CVD mortality | BMI >25 to <30 | BMI ≥18.5 to 25 | RR = 1.03 (0.95 to 1.12) | RR = 1.10 (1.03 to 1.16) | Meta-analysis (6) |
CHD mortality | BMI >25 to <30 | BMI ≥18.5 to 25 | RR = 1.10 (1.00 to 1.20) | RR = 1.16 (1.09 to 1.24) | Meta-analysis (6) |
BMI, body mass index (in kg/m2); CI, confidence interval; CVD, cardiovascular disease; CHD, coronary heart disease; RR, relative risk